Authors: Engberding, Niels; Wenger, Nanette K

Source: Expert Review of Cardiovascular Therapy, Volume 6, Number 8, September 2008 , pp. 1123-1134(12)

Publisher: Expert Reviews

Abstract:

Cardiovascular disease prevention is most effective when it is tailored for individual risk, since the benefit of any preventive intervention should outweigh its potential side effects and costs. Recognition of important gender differences in cardiovascular disease prevention has led to the formulation of specific guidelines for women. Based on a rigorous review of evidence, the 2007 American Heart Association guidelines for cardiovascular disease prevention in women differ little from the guidelines for men. The main difference pertains to the role of aspirin in primary cardiovascular prevention and to the appreciation of diabetes as a more detrimental risk factor in women than men. These guidelines provide a valuable framework to select the optimal preventive strategy for women of all ages, based on individual risk stratification, potentially supplemented with appropriate use of novel imaging modalities. Observational data continue to identify discrepancies between women and men, which target areas of need for future research.

Keywords: cardiovascular; prevention; risk assessment; women

Document Type: Research article

DOI: http://dx.doi.org/10.1586/14779072.6.8.1123

Affiliations: 1: Division of Cardiology, Emory University, School of Medicine ,49 Jesse Hill Jr Drive SE, Atlanta, GA 30303, USA

Publication date: 2008-09-01

More about this publication?

• Expert Review of Cardiovascular Therapy provides expert commentary on the clinical applications of the new medicines, therapeutic agents and diagnostics in cardiovascular disease. Coverage inculdes drug therapy, heart disease, vascular disorders, hypertension, cholesterol in cardiovascular disease, heart disease, stroke, heart failure and cardiovascular surgery.
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Information for Librarians
• Free Trials
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Cardiovascular Medicine ,  Pharmacology
• By this author: Engberding, Niels ;  Wenger, Nanette K

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers